To test the therapeutic value of ACE2, we generated a patient-derived xenograft (PDX) model with two HCC samples, one sample with low ACE expression and one sample with high ACE2 expression (Figure 7D). This evidence concerns the gene ACE and hepatocellular carcinoma.